Literature DB >> 17254005

Sjögren-Larsson syndrome.

Neil Gordon1.   

Abstract

Sjögren-Larsson syndrome is a recessively inherited syndrome caused by deficiency of fatty aldehyde dehydrogenase. The most common symptoms and signs are described, especially ichthyosis, spastic diplegia, and severe learning difficulties; but also other less frequent ones. Special investigations include sensory evoked potentials, electromyography, and proton magnetic resonance spectroscopy. Post-mortem examination shows, in particular, an accumulation of lipid substances in specific regions of the brain. The diagnosis depends on the measurement of fatty aldehyde dehydrogenase in cultured fibroblasts from skin biopsies, and by identifying known mutations by allele-specific polymerase chain reaction assay. Prenatal diagnosis is possible by using the same technique. The disorder is located on gene 17, and many mutations have been identified. Most mutations are unique to an affected family, but clinical variations may be due to unknown genetic and environmental factors. The deficiency of the enzyme impairs the oxidation of medium and long chain fatty aldehydes, and this may explain the link between the brain and skin disorders. The treatment of affected children needs input from a number of specialists, and their contributions are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17254005     DOI: 10.1111/j.1469-8749.2007.00152.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  13 in total

1.  An examination of pentafluorobenzoyl derivatization strategies for the analysis of fatty alcohols using gas chromatography/electron capture negative ion chemical ionization-mass spectrometry.

Authors:  John A Bowden; David A Ford
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-11-04       Impact factor: 3.205

2.  Clinico-radiological and genetic features of a common neuro-ichthyotic syndrome.

Authors:  Puneet Jain; Suvasini Sharma; Severine Drunat; Simon Samaan; Srishti Goel; Praveen Gulati; Satinder Aneja
Journal:  Indian J Pediatr       Date:  2014-12-24       Impact factor: 1.967

3.  Sjögren-Larsson syndrome: A study of clinical symptoms in six children.

Authors:  Sahana M Srinivas; Kn Vykunta Raju; Ravi Hiremagalore
Journal:  Indian Dermatol Online J       Date:  2014-04

4.  Optical coherence tomography aspect of crystalline macular dystrophy in Sjögren-Larsson syndrome.

Authors:  Salima Bhallil; Fouad Chraibi; Idriss Benatiya Andalloussi; Hicham Tahri
Journal:  Int Ophthalmol       Date:  2012-08-30       Impact factor: 2.031

5.  Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.

Authors:  Ujjawal Roy; Urmila Das; Alak Pandit; Anjan Debnath
Journal:  BMJ Case Rep       Date:  2016-04-19

Review 6.  Mental retardation and inborn errors of metabolism.

Authors:  A García-Cazorla; N I Wolf; M Serrano; U Moog; B Pérez-Dueñas; P Póo; M Pineda; J Campistol; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-08-14       Impact factor: 4.982

Review 7.  Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism.

Authors:  Peter M Elias; Mary L Williams; Walter M Holleran; Yan J Jiang; Matthias Schmuth
Journal:  J Lipid Res       Date:  2008-02-02       Impact factor: 5.922

Review 8.  Importance of lipids for upper motor neuron health and disease.

Authors:  Aksu Gunay; Heather H Shin; Oge Gozutok; Mukesh Gautam; P Hande Ozdinler
Journal:  Semin Cell Dev Biol       Date:  2020-12-13       Impact factor: 7.727

9.  A gatekeeper helix determines the substrate specificity of Sjögren-Larsson Syndrome enzyme fatty aldehyde dehydrogenase.

Authors:  Markus A Keller; Ulrich Zander; Julian E Fuchs; Christoph Kreutz; Katrin Watschinger; Thomas Mueller; Georg Golderer; Klaus R Liedl; Markus Ralser; Bernhard Kräutler; Ernst R Werner; Jose A Marquez
Journal:  Nat Commun       Date:  2014-07-22       Impact factor: 14.919

10.  A Turkish family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.

Authors:  Faruk Incecık; Ozlem M Herguner; Wiliam B Rizzo; Sakir Altunbasak
Journal:  Ann Indian Acad Neurol       Date:  2013-07       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.